article thumbnail

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare. It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? Visit www.nelsonadvisors.co.uk

article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

Real-world examples and case studies can showcase the platform's impact. Emphasize Local Partnerships: Partner with local companies and organizations to demonstrate Palantir's commitment to the UK healthcare ecosystem. Positive examples will build confidence in the platform's value. Buy, build or partner?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nvidia spends $1 Billion acquiring Two Israeli AI startups with massive HealthTech and Healthcare AI potential

Lloyd Price

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Lloyd Price

Growing Market: The global market for AI in healthcare is projected to reach astronomical figures in the coming years, reflecting the confidence in this technology. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

article thumbnail

Self-sovereign identity (SSI) - the future of Health Data?

Lloyd Price

Benefits for healthcare stakeholders: Streamlined patient onboarding: Verifiable credentials from SSI wallets can expedite patient registration and verification, reducing administrative burdens and improving wait times.

article thumbnail

Sovereign Health Fund: time to unlock the potential £5Bn ARR asset based on unique NHS datasets?

Lloyd Price

Exec Summary: The concept of a UK sovereign health fund based on NHS data is still in its early stages of development, but it has the potential to revolutionize the way healthcare is funded and delivered in the UK. The global drug development market is estimated to surpass $100bn by 2027. The value lies in sharing safely."